ArticleFrontiers in pharmacology2025

Correction: Resveratrol and Angiogenin-2 combined with PEGDA/TCS hydrogel for the targeted therapy of hypoxic bone defects via activation of the autophagy pathway.

Dehui Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.